Issues - Febbraio 2022

»
Nina Magnolo, Külli Kingo, Vivian Laquer, John Browning, Adam Reich, Jacek C Szepietowski, Deborah Keefe, Rafal Mazur, Prayashi Ghelani, Pascal Forrer, LindaAnn Wraith, Manmath Patekar

A phase 3 open-label, randomized multicenter study to evaluate efficacy and safety of secukinumab in pediatric patients with moderate to severe plaque psoriasis: 24-week results

J Am Acad Dermatol. 2022 Jan;86(1):122-130
Leggi abstract | Scarica ppt